Transcatheter aortis valve implantation with the self-expanding Portico valve system in an all-comers population: procedural and clinical outcomes
- 1 August 2018
- journal article
- research article
- Published by PCR Digital & Publishing in EuroIntervention
- Vol. 14 (6) , 621-628
Abstract
Aims: Transcatheter aortic valve implantation (TAVI) is an established therapy for patients with severe aortic stenosis (AS). The aim of this study was to evaluate the newer-generation Portico TAVI system in an all-comers population. Methods and results: This single-centre study included 216 patients with severe AS (Society of Thoracic Surgeons [STS] score 4.3 +/- 3.0%). The Portico valve was implanted using the transfemoral (91.2%), transsubclavian (5.6%) and transcaval (3.2%) access. Device success was achieved in 94.4% of cases. At 30 days, mortality and stroke rates were 2.3% and 0.5%, respectively. Early safety was achieved in 91.7% of cases. More-than-mild paravalvular leak (PVL), as assessed by echocardiogram, was observed in 3.4% of the patients, with rates of 4.9% and 1.9% in the first and second half of the cohort, respectively. A permanent pacemaker was implanted in 15.8% of those without prior pacemaker. with a rate of 11.1% in the second half of the cohort. At one year, incidence rates for all-cause mortality and stroke were 12.3% and 2.3%, respectively. In the low-risk group (STS <4%; n=128), Kaplan-Meier estimates at 30 days and one year were 0% and 7.5% for all-cause mortality and 0.8% and 2.2% for stroke, respectively. Haemodynamic improvements persisted over time with a mean transvalvular gradient of 7.0 +/- 3.0 mmHg at one-year follow-up. Conclusions: The Portico TAVI system was safe to implant and achieved a high device success rate. With learning curve effects, the device achieves lower rates of PVL and pacemaker implantation and provides adequate clinical and haemodynamic outcomes up to one year.Keywords
This publication has 14 references indexed in Scilit:
- Real-world experience using the ACURATE neo prosthesis: 30-day outcomes of 1,000 patients enrolled in the SAVI TF registryEuroIntervention, 2018
- Real-world procedural and 30-day outcome using the Portico transcatheter aortic valve prosthesis: A large single center cohortInternational Journal of Cardiology, 2018
- Implantation and 30-Day Follow-Up on All 4 Valve Sizes Within the Portico Transcatheter Aortic Bioprosthetic FamilyJACC: Cardiovascular Interventions, 2017
- Feasibility and safety of transfemoral sheathless portico aortic valve implantation: Preliminary results in a single center experienceCatheterization and Cardiovascular Interventions, 2017
- Transcatheter aortic valve replacement with the Portico valve: one-year results of the early Canadian experienceEuroIntervention, 2017
- Efficacy and safety of the Lotus Valve System for treatment of patients with severe aortic valve stenosis and intermediate surgical risk: Results from the Nordic Lotus-TAVR registryInternational Journal of Cardiology, 2016
- Transcatheter Aortic Valve Replacement Using the Portico System: 10 Things to RememberJournal of Interventional Cardiology, 2016
- Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk PatientsNew England Journal of Medicine, 2016
- Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantationEuropean Heart Journal, 2013
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document†European Heart Journal, 2012